523 related articles for article (PubMed ID: 24502325)
21. Patient information. Hormone replacement therapy: frequently asked questions.
Cleve Clin J Med; 2002 Sep; 69(9):680-1. PubMed ID: 12222971
[No Abstract] [Full Text] [Related]
22. Micronized progesterone, progestins, and menopause hormone therapy.
Hipolito Rodrigues MA; Gompel A
Women Health; 2021 Jan; 61(1):3-14. PubMed ID: 32957843
[TBL] [Abstract][Full Text] [Related]
23. Treatment of menopausal vasomotor symptoms.
Obstet Gynecol; 2005 May; 105(5 Pt 1):1137-9. PubMed ID: 15863558
[No Abstract] [Full Text] [Related]
24. Managing the menopause: An update.
Roberts H; Hickey M
Maturitas; 2016 Apr; 86():53-8. PubMed ID: 26921929
[TBL] [Abstract][Full Text] [Related]
25. Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: a comprehensive review.
Utian WH
Health Qual Life Outcomes; 2005 Aug; 3():47. PubMed ID: 16083502
[TBL] [Abstract][Full Text] [Related]
26. Treating vasomotor symptoms of menopause: the nurse practitioner's perspective.
Alexander IM; Moore A
J Am Acad Nurse Pract; 2007 Mar; 19(3):152-63. PubMed ID: 17341283
[TBL] [Abstract][Full Text] [Related]
27. [Menopause - facts and controversies].
Pertyński T; Stachowiak G
Endokrynol Pol; 2006; 57(5):525-34. PubMed ID: 17133318
[TBL] [Abstract][Full Text] [Related]
28. Oestrogen replacement in postmenopausal women.
Sassarini J; Lumsden MA
Age Ageing; 2015 Jul; 44(4):551-8. PubMed ID: 26070875
[TBL] [Abstract][Full Text] [Related]
29. Menopausal hormone therapy and menopausal symptoms.
Al-Safi ZA; Santoro N
Fertil Steril; 2014 Apr; 101(4):905-15. PubMed ID: 24613533
[TBL] [Abstract][Full Text] [Related]
30. Can we predict who will experience recurrent vasomotor symptoms after stopping hormone therapy?
Gracia CR; Sondheimer S
Menopause; 2010; 17(1):10-1. PubMed ID: 20010441
[No Abstract] [Full Text] [Related]
31. Differential effects of estrogen-androgen and estrogen-only therapy on vasomotor symptoms, gonadotropin secretion, and endogenous androgen bioavailability in postmenopausal women.
Simon J; Klaiber E; Wiita B; Bowen A; Yang HM
Menopause; 1999; 6(2):138-46. PubMed ID: 10374221
[TBL] [Abstract][Full Text] [Related]
32. [Indications critically evaluated: hormone-domain hot flashes].
MMW Fortschr Med; 2003 Nov; 145(46):5-8. PubMed ID: 14699822
[No Abstract] [Full Text] [Related]
33. Local and systemic options for hormone replacement therapy.
Gilliam ML
Int J Fertil Womens Med; 2001; 46(4):222-7. PubMed ID: 11563833
[TBL] [Abstract][Full Text] [Related]
34. Emerging hormonal treatments for menopausal symptoms.
Genazzani AR; Komm BS; Pickar JH
Expert Opin Emerg Drugs; 2015 Mar; 20(1):31-46. PubMed ID: 25557757
[TBL] [Abstract][Full Text] [Related]
35. Hot flashes and androgens: a biological rationale for clinical practice.
Notelovitz M
Mayo Clin Proc; 2004 Apr; 79(4 Suppl):S8-13. PubMed ID: 15065632
[TBL] [Abstract][Full Text] [Related]
36. Vasomotor symptoms in menopause: physiologic condition and central nervous system approaches to treatment.
Rapkin AJ
Am J Obstet Gynecol; 2007 Feb; 196(2):97-106. PubMed ID: 17306645
[TBL] [Abstract][Full Text] [Related]
37. Effects of estrogen plus progestin on health-related quality of life.
Lopes AA; Latado A; Lopes GB
N Engl J Med; 2004 Feb; 350(6):622. PubMed ID: 14762196
[No Abstract] [Full Text] [Related]
38. The Art of Hormone Replacement Therapy (HRT) in Menopause Management.
Cameron CR; Cohen S; Sewell K; Lee M
J Pharm Pract; 2024 Jun; 37(3):736-740. PubMed ID: 37002679
[TBL] [Abstract][Full Text] [Related]
39. Alternatives for menopause.
Ernst E; Borrelli F
Arch Intern Med; 2007 Mar; 167(5):515; author reply 515-6. PubMed ID: 17353503
[No Abstract] [Full Text] [Related]
40. It might be wise to consider adding androgen to the estrogen or estrogen-progestin regimens in the appropriate patients.
Gelfand MM
Menopause; 2004; 11(5):505-7. PubMed ID: 15356402
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
